Basic Information
Arcoris Bio develops nanotechnology-based reagents and solutions designed to enhance and simultaneously detect RNA and proteins in biological samples. The company’s platform integrates a nanotechnology-based signal amplification system, enabling truly simultaneous multiplex target detection for multimodal applications such as immunofluorescence and imaging-quality cytometry. Designed for ease of use without the need for specialized laboratory equipment, it empowers cell biologists and genomics researchers to perform accurate, high-throughput biomolecular quantification, complementing other data analysis methods like RNA sequencing.
Arcoris Bio
Switzerland
15~50 people
January 01, 2022
--
--

